SANRENO THERAPEUTICS
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore (the “Territory”). SanReno Therapeutics formed with JV of Chinook Therapeutics and Frazier Healthcare Partners and Pivotal bioVenture Partners China.
SANRENO THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
40 M USD
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Funding Round - SanReno Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Funding Round - SanReno Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Funding Round - SanReno Therapeutics
Versant Ventures
Versant Ventures investment in Funding Round - SanReno Therapeutics
More informations about "SanReno Therapeutics"
SanReno Therapeutics Announces Acquisition by Novartis in …
Jan 5, 2024 SanReno Therapeutics is a leading clinical-stage enterprise specializing in the strategic development, exploration, and commercialization of revolutionary therapies tailored …See details»
SanReno Therapeutics Announces Acquisition by Novartis in …
Jan 5, 2024 SanReno Therapeutics, a clinical-stage company specializing in the discovery, development, and commercialization of innovative therapies for kidney diseases, today …See details»
SanReno Therapeutics Company Profile 2024: …
SanReno Therapeutics General Information Description. Developer of biotech therapies focused on kidney diseases and related therapeutic areas. The company is committed to the research and development, production and …See details»
SanReno Therapeutics Announces Acquisition by …
Jan 5, 2024 Novartis acquires SanReno Therapeutics, a clinical-stage company specializing in kidney disease therapies, solidifying its commitment to groundbreaking treatments. SanReno, now an indirect subsidiary of Novartis, …See details»
SanReno Therapeutics Announces Acquisition by Novartis in
SHANGHAI, Jan. 5, 2024 /PRNewswire/ -- SanReno Therapeutics, a clinical-stage company specializing in the discovery, development, and commercialization of innovative therapies for …See details»
SanReno Therapeutics announces acquisition by …
Jan 11, 2024 SanReno Therapeutics has announced that it has been acquired by Novartis, becoming an indirect, wholly-owned subsidiary of Novartis. The investors that helped found SanReno—including Pivotal bioVenture Partners …See details»
Novartis acquires SanReno Therapeutics - 2024-01-05 - Crunchbase
Jan 5, 2024 SanReno Therapeutics SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies. Acquiring Organization: Novartis Novartis is a …See details»
SanReno Therapeutics Announces Acquisition by Novartis in …
Jan 5, 2024 SanReno Therapeutics is a leading clinical-stage enterprise specializing in the strategic development, exploration, and commercialization of revolutionary therapies tailored …See details»
SanReno Therapeutics - Funding, Financials, Valuation & Investors
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. …See details»
SanReno Therapeutics--信瑞诺
SanReno Therapeutics is a clinical-stage biotech focused on kidney diseases and related therapeutic areas. SanReno’s founding investors and partners including Chinook …See details»
Exploring the Latest ETA Antagonists Deal by SanReno …
Jan 5, 2024 About SanReno Therapeutics (Shanghai) SanReno Therapeutics (Shanghai) Co., Ltd is a biomedicine organization founded in 2021, with a focus on developing therapeutics for …See details»
SanReno Therapeutics(Shanghai)Co.,Ltd - Drug pipelines, Patents ...
Explore SanReno Therapeutics(Shanghai)Co.,Ltd with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, Disease Domain:Immune System Diseases, …See details»
Chinook Therapeutics Announces Formation of SanReno …
Nov 30, 2021 Chinook Therapeutics Announces Formation of SanReno Therapeutics, a Joint Venture to Develop Kidney Disease Therapies in China Chinook Therapeutics, Inc. Tue, Nov …See details»
Chinook Therapeutics Announces Formation of SanReno
Nov 30, 2021 SanReno will be responsible for all development, manufacturing and commercialization costs for atrasentan and BION-1301 in the Territory, while Chinook will …See details»
SanReno Therapeutics - VentureRadar
" SanReno Therapeutics is a joint venture between Chinook Therapeutics and an investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China, founded …See details»
SanReno Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. SanReno Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 7. About. …See details»
Novartis completes acquisition of Chinook Therapeutics
Basel, August 11, 2023 — Novartis today announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company focused on the …See details»
Chinook Therapeutics Announces Formation of SanReno …
Nov 30, 2021 SEATTLE , WA – Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of …See details»
sanreno.com
Sanreno.comSee details»